Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
about
Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantationComparison of an automated nucleic acid extraction system with the column-based procedureStandardization of Nucleic Acid Tests for Clinical Measurements of Bacteria and Viruses.Multicenter comparison of laboratory performance in cytomegalovirus and Epstein-Barr virus viral load testing using international standards.Cytomegalovirus Infection Management in Allogeneic Stem Cell Transplant Recipients: a National Survey in Spain.Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection.Comparison of six real-time PCR assays for qualitative detection of cytomegalovirus in clinical specimens.Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value?Quantification of cytomegalovirus viral load.Comparison of automated nucleic acid extraction methods for the detection of cytomegalovirus DNA in fluids and tissues.Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients.Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey.Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.Performance Evaluation of the Real-Q Cytomegalovirus (CMV) Quantification Kit Using Two Real-Time PCR Systems for Quantifying CMV DNA in Whole BloodAre We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples.Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood.Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8(+) T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation.Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.Comparative evaluation of the QIAsymphony RGQ system with the easyMAG/R-gene combination for the quantitation of cytomegalovirus DNA load in whole blood.Detection and pharmacokinetics of a cytomegalovirus (CMV) DNA plasmid in human plasma during a clinical trial of an intramuscular CMV vaccine in hematopoietic stem cell transplant recipients.An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.Frequent detection of cytomegalovirus (CMV) DNA in the lower respiratory tract in CMV-seropositive pediatric patients with underlying chronic bronchopulmonary diseases lacking canonical immunosuppression.Management of cytomegalovirus infection in haemopoietic stem cell transplantation.
P2860
Q26826856-394A643F-06A6-490F-B3F5-810142A6486DQ35426867-3C9D00C8-6844-470D-938A-A4920B2741B1Q35757751-4B5CC2AF-32DF-4DAA-B7F9-2E82C6546AF8Q35785478-95EA4C4D-D526-4B33-913D-5F0CE09ABA73Q35868731-A4CDA2B4-BEBA-400E-AE56-A05A8CEE0F24Q36306393-B7FD8584-A020-481D-B333-95DE0054124EQ36505218-E25E6258-6CCB-4693-A700-313817011F81Q37470419-02D9D51F-B121-41DC-A878-55106C59FC84Q37546310-49C19093-8F0D-4FC1-98A4-75E14558DBDBQ38171537-03F8E8DC-FF70-4723-A013-EC6439D79737Q38875533-09D3A0D4-6616-4FA6-AFE6-0988BC594E04Q39281206-0958C33E-C5F8-4D51-B184-7CC82412595BQ39296120-51D27346-CE8C-4414-B616-E37576F45C6FQ40101845-1B944A73-2FA0-4B55-8724-592F9575ECC1Q40557237-95D036B0-F646-4398-9FA1-EECC55249D1BQ40698934-13C5863E-A600-46BD-8231-B7E57ADAC69DQ40880905-52FB15A2-139C-4529-8381-810CB7985A1BQ41104283-F8F0A581-E607-44EF-8903-74A2B97D6A24Q41172989-FF4B4860-499F-44AD-9A68-53CF8C14177FQ41606013-BE46831F-390F-494F-8717-D5DE8C10D381Q42181010-AE671EA3-F179-4AA6-A9BD-4F3AF9B3DEECQ42269481-4ECE1B42-C065-483A-888F-8559413354C3Q43912964-14C184CC-BD3C-401B-9305-EE0C94D5D687Q44714539-229176DA-1EDF-426F-9AB0-3C7CC68582BE
P2860
Comparative evaluation of three automated systems for DNA extraction in conjunction with three commercially available real-time PCR assays for quantitation of plasma Cytomegalovirus DNAemia in allogeneic stem cell transplant recipients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Comparative evaluation of thre ...... em cell transplant recipients.
@ast
Comparative evaluation of thre ...... em cell transplant recipients.
@en
type
label
Comparative evaluation of thre ...... em cell transplant recipients.
@ast
Comparative evaluation of thre ...... em cell transplant recipients.
@en
prefLabel
Comparative evaluation of thre ...... em cell transplant recipients.
@ast
Comparative evaluation of thre ...... em cell transplant recipients.
@en
P2093
P2860
P356
P1476
Comparative evaluation of thre ...... em cell transplant recipients.
@en
P2093
Beatriz Muñoz-Cobo
Carlos Solano
David Navarro
Dayana Bravo
Elisa Costa
María José Remigia
María Ángeles Clari
P2860
P304
P356
10.1128/JCM.00785-11
P407
P577
2011-06-22T00:00:00Z